Dishman Pharma Surges On Completion Of FDA Inspection of Gujarat Facility

Dishman Pharmaceuticals and Chemicals shares gained as much as 9 per cent to touch a day's high of Rs 149 after the company announced that the inspection at its Bavla facility in Gujarat has been successfully completed by US Food and Drug Regulator. In a filing to BSE, Dishman Pharmaceuticals and Chemicals said that renewal of US FDA inspection of Company's Bavla facility has been successfully completed on July 08, 2016. Shares of ...